Qiagen Acquires Shenzhen PG Biotech
Filed in archive Corporate and Industrial News on September 27, 2005

QIAGEN N.V. has entered into an agreement to purchase all
outstanding shares of Shenzhen PG Biotech Co Ltd based in
Shenzhen, China. PG Biotech is a leading developer, manufacturer and supplier
of polymerase chain reaction (PCR)-based molecular diagnostic kits in China.
The acquisition will expand QIAGEN's position as a leading provider of
molecular Diagnostics solutions to OEM partners and customers in the rapidly
growing Asian markets. Read more about the terms of the acquisition here.

Permalink: Qiagen Acquires Shenzhen PG Biotech
Tags: PCR diagnostics biotech shenzhen acquires acquires+shenzhen shenzhen+biotech qiagen+acquires
Vote for Qiagen Acquires Shenzhen PG Biotech:
|
Rating: 9.00 out of 4 vote(s) cast.
|
Most Popular
Best of
Biotech Hubs and Facilities
Biotech/Science Blogs
Corporate and Industrial News
Diagnostics, Methodologies and Instrumentation
Did you know
Drugs, Vaccines and Therapeutics
Energy, Environment and Ecology
Food and Agriculture
Gene Therapy
Genomics, Proteomics and Bioinformatics
Information About
Meetings and Other Events
Microbiology
Misc
Nanomedicine
Other Biotechnology News
Patents and Intellectual Property Rights
Quick introduction
Stem Cells
